TY - JOUR T1 - Human Biodistribution and Radiation Dosimetry of <sup>82</sup>Rb JF - Journal of Nuclear Medicine JO - J Nucl Med SP - 1592 LP - 1599 DO - 10.2967/jnumed.110.077669 VL - 51 IS - 10 AU - Srinivasan Senthamizhchelvan AU - Paco E. Bravo AU - Caroline Esaias AU - Martin A. Lodge AU - Jennifer Merrill AU - Robert F. Hobbs AU - George Sgouros AU - Frank M. Bengel Y1 - 2010/10/01 UR - http://jnm.snmjournals.org/content/51/10/1592.abstract N2 - Prior estimates of radiation-absorbed doses from 82Rb, a frequently used PET perfusion tracer, yielded discrepant results. We reevaluated 82Rb dosimetry using human in vivo biokinetic measurements. Methods: Ten healthy volunteers underwent dynamic PET/CT (6 contiguous table positions, each with separate 82Rb infusion). Source organ volumes of interest were delineated on the CT images and transferred to the PET images to obtain time-integrated activity coefficients. Radiation doses were estimated using OLINDA/EXM 1.0. Results: The highest mean absorbed organ doses (μGy/MBq) were observed for the kidneys (5.81), heart wall (3.86), and lungs (2.96). Mean effective doses were 1.11 ± 0.22 and 1.26 ± 0.20 μSv/MBq using the tissue-weighting factors of the International Commission on Radiological Protection (ICRP), publications 60 and 103, respectively. Conclusion: Our current 82Rb dosimetry suggests reasonably low radiation exposure. On the basis of this study, a clinical 82Rb injection of 2 × 1,480 MBq (80 mCi) would result in a mean effective dose of 3.7 mSv using the weighting factors of the ICRP 103—only slightly above the average annual natural background exposure in the United States (3.1 mSv). ER -